FDA Okays Tablet Version of Acalabrutinib for All Indications

The new formulation can be taken with proton pump inhibitors and other gastric acid reducers.
FDA Approvals
The new formulation can be taken with proton pump inhibitors and other gastric acid reducers.
FDA Approvals